why choose us

First received: August 30, 2022

Clinical Trial: Blood-Based Biomarkers to Inform Treatment and Radiation Therapy Decisions for HPV Associated Oropharyngeal Squamous Cell Head and Neck Cancers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma

Study Type: INTERVENTIONAL


Official Title: DART 2.0: ctHPV-DNA Informed De-Escalated Adjuvant and Definitive Radiation Therapy

Brief Summary: This phase II trial examines the use of blood-based biomarkers is to help inform decision making for treatment and radiation therapy for patients with human papillomavirus (HPV) positive oropharyngeal squamous cell cancers.The standard treatments for head and neck cancers are radiation therapy with chemotherapy or surgery potentially followed by radiation therapy with or without chemotherapy.Radiation therapy uses high energy rays to kill tumor cells and shrink tumors.Giving chemotherapy along with radiation may…

Read more